Overview

Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest

Status:
Completed
Trial end date:
2019-06-02
Target enrollment:
Participant gender:
Summary
To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
Kaneka Medical America LLC
Kaneka Pharma America LLC
Treatments:
Ubiquinone